Nesco Regulatory Approval

Financial Results

Nesco Q2 FY27 Results: Net Profit ₹105.2 Cr, Down 11.5% YoY

Nesco Ltd reported revenue from operations of ₹228.4 Cr (-4.5% YoY) and net profit of ₹105.2 Cr (-11.5% YoY) for Q2 FY27.

Key figure

Net profit ₹105.2 Cr · -11.5% YoY

Other Announcement

Nesco Other Announcement

Nesco Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under Regulation 31(1)(b).

Board Meeting Date

Nesco Board Meeting Date

NESCO Ltd has scheduled a Board meeting for 23 October 2026 to approve Q1 FY27 unaudited financial results. The trading window remains closed until 48 hours post-results.

Other Announcement

Nesco Other Announcement

Nesco Limited filed its quarterly Regulation 74(5) compliance certificate for the period ended 30 September 2026, as confirmed by its Registrar, MUFG Intime India Pvt. Ltd.

Legal & Regulatory

Nesco Legal & Regulatory

Nesco Limited received a penalty of ₹2.10 Crore from National Highways Logistics Management Limited due to project implementation delays. The company plans to contest this.

Value

₹2.10 Cr

Results Correction

Nesco Results Correction

Nesco Limited submitted a revised response to an exchange query regarding its financial results for the quarter ended June 30, 2026, confirming no discrepancies.

Regulatory ApprovalGrasim Industries Ltd GRASIMAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.